ロード中...
Tumour-infiltrating regulatory T cell density before neoadjuvant chemoradiotherapy for rectal cancer does not predict treatment response
Neoadjuvant (preoperative) chemoradiotherapy (CRT) decreases the risk of rectal cancer recurrence and reduces tumour volume prior to surgery. However, response to CRT varies considerably between individuals and factors associated with response are poorly understood. Foxp3(+) regulatory T cells (Treg...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5386723/ https://ncbi.nlm.nih.gov/pubmed/28177891 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15048 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|